clinical trials | Market Exclusive

Home Tags Clinical trials

Zafgen is Preparing to Mount a Beloranib Defense

ME Staff - January 25, 2016 0

Post-Holiday Action: Movers and Shakers in Biotech

Jennifer Aldershot - December 28, 2015 0

A Look at the Science Behind Bayer’s Latest Buy

Roger Hannington - December 22, 2015 0

Is Bellicum A Worthy Index/Portfolio Addition?

Jennifer Aldershot - December 21, 2015 0

Array is Sitting on a Billion Dollar Melanoma Blockbuster

Roger Hannington - December 16, 2015 0

Atara’s Discontinuation Paints it as a Potential Short

- December 15, 2015 0

The Latest Raptor Announcement May Be More Positive Than Markets Think

- December 11, 2015 0

This Company Could Be An Opportunity To Buy Into A Dramatic...

Jennifer Aldershot - November 26, 2015 0

Here’s Why Markets Overlooked Idera’s Financials

Jennifer Aldershot - November 12, 2015 0

Here’s Why These Three Biotech Giants Just Gained Strength

- November 3, 2015 0

1...567 Page 6 of 7

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: clinical trials